Home / Blog / The Chobani Zero-Sugar Label Case: Why It Matters for Fatty Liver
The Chobani Zero-Sugar Label Case: Why It Matters for Fatty Liver
2026-08-05 · FattyLiverFood Research Team
A federal appeals court on August 4, 2026, revived a consumer fraud lawsuit over Chobani's "Zero Sugar" yogurt line. The dispute turns on allulose, a natural sweetener that provides sweetness with minimal calories. The plaintiffs say the product, labeled zero sugar, contains 4 grams of allulose per serving - and under the strict federal definition, "sugar free" means under 0.5 grams of sugar per serving. The FDA filed a friend-of-the-court brief stating that allulose falls within the legal definition of sugar as a monosaccharide.
The case matters for people managing fatty liver because it sits at the intersection of two things this site cares about: what labels actually mean, and how sweeteners - added or not - affect the liver. The FDA has not yet issued a final rule on how allulose counts on nutrition labels, and a 2020 enforcement discretion statement left room for interpretation. The court decided that the question of what a reasonable consumer understands by "zero sugar" is a fact question that must go to trial.
Nutritionally, the two sides are not fully opposed. Chobani notes allulose does not raise blood glucose like traditional sugar, which is true - it is largely unmetabolized and produces little to no glycemic response. The dispute is about labeling law, not about whether allulose behaves like sucrose in the body. Both statements can be true at once, and the trial will sort out what the label promised.
Sweeteners and the liver: what the label does and does not tell you
For liver health, the distinction that matters most is between foods that deliver glucose and fructose quickly and foods that do not. Traditional added sugar - sucrose and high-fructose corn syrup - delivers both, and the fructose fraction is metabolized largely in the liver, where it feeds de novo lipogenesis when intake is high. That is the metabolic route behind the added-sugar veto in the rating engine on this site.
Allulose sits in a different category: it is a rare sugar that is absorbed but largely excreted unchanged, which is why it does not spike glucose. The dairy entries in the database show the pattern clearly - plain yogurt rated within the moderation-to-recommended range carries protein and modest carbohydrate, while sweetened yogurt products get downgraded on added sugar. The sweetener used matters, but so does the total carbohydrate picture of the product.
The practical lesson from the Chobani case is about reading past the front of the package. "Zero sugar" claims are about legal definitions, and the ingredients list and nutrition facts panel carry the details. For a liver-conscious pattern, the question is not just whether sugar is zero on the label, but what the product is made of overall - protein, fat, carbohydrate, and how the sweetening is achieved.
What the label fight reveals about reading food packages
The Chobani case is, at its core, a lesson in how front-of-package claims are regulated. The "Zero Sugar" claim sits on a product that contains allulose - a sweetener the FDA's own guidance had treated as not counting toward total sugar in enforcement terms, but that the strict statutory definition still captures as a monosaccharide. The appeals court's decision to let the case go to trial means the question of what consumers reasonably expect from the claim will be decided by evidence, not by either side's marketing.
For people building a liver-conscious pattern, the transferable skill is simple: read the nutrition facts panel and the ingredients list, not just the front claim. A product can truthfully say "zero sugar" under one interpretation while still being a sweet, ultra-processed food with refined carbohydrate. The label is a legal document; the panel is the nutritional reality.
The dairy category in the database shows how this plays out in practice. Plain yogurt rates favorably - protein, calcium, modest carbohydrate, no added sugar veto. The moment sweetness is added, whether through sugar or through sweeteners, the product changes category. The verdicts track the composition, not the marketing language, which is exactly the discipline the Chobani dispute argues for.
Allulose, glucose, and the liver: the metabolic detail
Digging one level deeper into the sweetener science helps explain why the label dispute exists. Allulose has the same chemical formula as fructose but a different structure that the body largely does not metabolize - most of it is absorbed and excreted in urine. That is why it produces little glucose response despite tasting sweet. The FDA's enforcement discretion reflected this: for labeling purposes, it did not count toward sugar, pending formal rulemaking.
From a liver perspective, the distinction between allulose and fructose is exactly the one that matters. Fructose is metabolized primarily in the liver, and high intake feeds de novo lipogenesis - the pathway that turns dietary sugar into liver fat. Allulose bypasses most of that. So a product sweetened with allulose is metabolically different from one sweetened with sugar, even when both are labeled around the "sugar" question. The database on this site scores the composition, not the sweetener claim - and the total carbohydrate, protein, and fat profile of the yogurt is what the verdict reflects.
Allulose, glucose, and the liver: the metabolic detail
How we read the label case
Label-reading posts are where our database's criteria meet the grocery aisle, and this one came from a reader question about a specific product line. Our data editor pulled the product's nutrition numbers, checked the added-sugar question against the label (zero added sugar is not the same as zero sugar), and compared it with the plain Greek yogurt entry already in the database. The verdict logic is identical: added sugar veto, saturated share, processing.
We also walked through how the database would rate the flavored versions if the sugar number changes - because that is the tool readers actually use in the store. The label is data, and we treat it the way we treat USDA data: verify before trusting.
Common Questions
Is allulose safe for fatty liver?
Allulose is a rare sugar that is largely not metabolized, so it produces little glucose response. Research on its long-term effects is still accumulating. For liver health, it behaves differently from traditional sugar, but the total product composition matters more than any single sweetener.
What does "zero sugar" legally mean?
Under FDA regulations, "sugar free" means less than 0.5 grams of sugar per serving. The Chobani lawsuit disputes whether allulose counts toward that figure - a question currently headed to trial after the appeals court revived the case.
Does artificial sweetener harm the liver?
The evidence is mixed and dose-dependent. Non-nutritive sweeteners in moderation do not show the same liver-fat pathway as traditional sugar, but some research raises questions about gut microbiome effects. The bigger liver risk is the added sugar in sweetened products, not the sweetener itself.
Should I avoid zero-sugar products?
Not automatically. A zero-sugar yogurt with protein and moderate carbohydrate can fit a liver-conscious pattern. The caution is for products that replace sugar with sweeteners while remaining ultra-processed or low in real nutrients - read the whole label, not the front claim.
What yogurt should I choose for fatty liver?
Plain, unsweetened yogurt generally rates best in the database - it carries protein and calcium with modest carbohydrate. If sweetness is needed, adding fruit or a small amount of a measured sweetener beats buying a pre-sweetened product.
This is dietary reference information, not medical advice. Always consult your healthcare provider before making dietary changes.